N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group. [electronic resource]
Producer: 20150406Description: 1079-86 p. digitalISSN:- 1432-1041
- Adult
- Antitubercular Agents -- adverse effects
- Arylamine N-Acetyltransferase -- genetics
- Asia -- epidemiology
- Case-Control Studies
- Chemical and Drug Induced Liver Injury -- epidemiology
- Drug Therapy, Combination
- Ethnicity -- genetics
- Europe -- epidemiology
- Female
- Genetic Predisposition to Disease
- Genotype
- Humans
- Isoniazid -- adverse effects
- Male
- Middle Aged
- Odds Ratio
- Risk Factors
- Tuberculosis -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.